๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT ยท Real-Time Price ยท USD
10.23
-0.49 (-4.57%)
Nov 20, 2026, 4:00 PM EST - Market closed

4D Molecular Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
96.0685.210.0420.723.1318.04
Revenue Growth
79953.33%230194.59%-99.82%562.29%-82.65%32.52%
Gross Profit
-161.38-107.29-141.26-76.37-77.12-43.32
Operating Income
-213.95-156.35-187.84-112.87-110.03-71.33
Net Income
-200.35-140.11-160.87-100.84-107.49-71.32
Earnings Per Share
-2.92-2.42-2.98-2.58-3.32-2.57
EPS Growth
------

Revenue by Geography

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Japan
-85----
United States
0.360.210.0420.160.040.12
Total
96.0685.210.0420.723.1318.04

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
375.03514.03505.46299.19218.46315.43
Total Debt
38.4121.4124.6114.6716.1216.45
Net Cash (Debt)
336.62492.62480.85284.52202.34298.98
Net Cash Growth
-3.81%2.45%69.01%40.61%-32.32%8.04%
Net Cash Per Share
4.908.508.917.276.2510.78

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-166.28-109.08-134.59-75.79-86.69-69.13
Capital Expenditures
-0.03-0.54-3.79-2.77-11.54-9.11
Free Cash Flow
-166.32-109.62-138.37-78.56-98.22-78.24
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-167.99%-125.91%----240.17%
Operating Margin
-222.71%-183.49%-507678.38%-544.65%-3516.52%-395.46%
Pretax Margin
-208.56%-164.43%-434778.38%-486.59%-3435.41%-395.37%
Profit Margin
-208.56%-164.43%-434778.38%-486.59%-3435.41%-395.37%
FCF Margin
-173.13%-128.65%-373975.68%-379.11%-3139.05%-433.77%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
6.005.036959.1441.80229.9339.09